Fueling Next-Generation MS Disease Progression Research with Valhalla Foundation Support – Read the Release

Recent Announcements & Press

Octave CEO Doug Biehn on NYSE Floor Talk with Judy Shaw

High Notes: Octave Biosciences’ Protein Panel Predicts MS Trajectory- Inside Precision Medicine

Octave® Bioscience, Inc. Announces Publication in Nature Communications- Businesswire

Octave Note

ECTRIMS Preview: A Strong Presence at an Important Meeting

MRI: An Imperfect Gold Standard

Media Library

living well

Women to Watch Media with Susan Rocco

living well

Personalized Medicine for MS

living well

Digital Health & MS